High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study
Phase of Trial: Phase I/II
Latest Information Update: 05 Jul 2018
At a glance
- Drugs Atorvastatin (Primary)
- Indications Renal failure
- Focus Adverse reactions
- Acronyms HAFF
- 26 Jun 2018 Status changed from not yet recruiting to recruiting.
- 10 Oct 2017 Planned End Date changed from 1 Nov 2019 to 31 Dec 2019.
- 10 Oct 2017 Planned primary completion date changed from 1 Sep 2019 to 31 Dec 2019.